Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (A GUSTO IV substudy)

American Journal of Cardiology

Volumn 97, Issue 2, 2006, Pages 167-172

  James, Stefan K ^a   Lindahl, Bertil ^a   Timmer, Jorik R ^d   Ottervanger, Jan Paul ^d   Siegbahn, Agneta ^a   Stridsberg, Mats ^a   Armstrong, Paul ^b   Califf, Robert ^c   Wallentin, Lars ^a   Simoons, Maarten L ^d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ALBERTA   (Canada)

^c DUKE UNIVERSITY   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 6; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SYNDROME; TROPONIN T;

EID: 31344471934     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.08.036     Document Type: Article

References (22)

1. B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 343 2000 1139 1147
2. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, C.H. McCabe, C. Hall, C.P. Cannon, E. Braunwald The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
3. S.K. James, B. Lindahl, A. Siegbahn, M. Stridsberg, P. Venge, P. Armstrong, E.S. Barnathan, R. Califf, E.J. Topol, M.L. Simoons, L. Wallentin N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
4. S.K. James, B. Lindahl, A. Siegbahn, M. Stridsberg, P. Venge, L. Wallentin, P. Armstrong, E.S. Barnathan, R. Califf, E.M.S. Topol Heart-kidney interactions in ischemic syndromes Circulation 109 2004 31 32
5. S.K. James, P. Armstrong, E. Barnathan, R. Califf, B. Lindahl, A. Siegbahn, M.L. Simoons, E.J. Topol, P. Venge, L. Wallentin Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. A GUSTO-IV substudy J Am Coll Cardiol 41 2003 916 924
6. A.M. Richards, M.G. Nicholls, T.G. Yandle, C. Frampton, E.A. Espiner, J.G. Turner, R.C. Buttimore, J.G. Lainchbury, J.M. Elliott, H. Ikram Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
7. T. Omland, A. Persson, L. Ng, R. O'Brien, T. Karlsson, J. Herlitz, M. Hartford, K. Caidahl N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
8. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
9. GUSTO-IV-ACS Investigators Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization the GUSTO IV-ACS randomized trial Lancet 357 2001 1915 1924
10. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
11. R.J. Aviles, A.T. Askari, B. Lindahl, L. Wallentin, G. Jia, E.M. Ohman, K.W. Mahaffey, L.K. Newby, R.M. Califf, M.L. Simoons Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 346 2002 2047 2052
12. K. Malmberg, S. Yusuf, H.C. Gerstein, J. Brown, F. Zhao, D. Hunt, L. Piegas, J. Calvin, M. Keltai, A. Budaj Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry Circulation 102 2000 1014 1019
13. V. Mathew, B.J. Gersh, B.A. Williams, W.K. Laskey, J.T. Willerson, R.T. Tilbury, B.R. Davis, D.R. Holmes Jr Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 109 2004 476 480
14. A. Norhammar, K. Malmberg, E. Diderholm, B. Lagerqvist, B. Lindahl, L. Ryden, L. Wallentin Diabetes mellitus the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization J Am Coll Cardiol 43 2004 585 591
15. A. Norhammar, K. Malmberg, L. Ryden, P. Tornvall, U. Stenestrand, L. Wallentin Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction Eur Heart J 24 2003 838 844
16. M. Weber, T. Dill, R. Arnold, M. Rau, O. Ekinci, K.D. Muller, A. Berkovitsch, V. Mitrovic, C. Hamm N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris Am Heart J 148 2004 612 620
17. H.S. Lim, A.D. Blann, G.Y. Lip Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus relationships to cardiovascular disease and risk factor intervention Circulation 109 2004 2524 2528
18. A. Scholin, A. Siegbahn, L. Lind, C. Berne, G. Sundkvist, E. Bjork, F.A. Karlsson CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes Diabetes Metab Res Rev 20 2004 205 210
19. R. Marfella, M. Siniscalchi, K. Esposito, A. Sellitto, U. De Fanis, C. Romano, M. Portoghese, S. Siciliano, F. Nappo, F.C. Sasso Effects of stress hyperglycemia on acute myocardial infarction role of inflammatory immune process in functional cardiac outcome Diabetes Care 26 2003 3129 3135
20. R. Marfella, D. Giugliano Stress hyperglycaemia and death after myocardial infarction Lancet 355 2000 1647
21. M.R. Cusack, M.S. Marber, P.D. Lambiase, C.A. Bucknall, S.R. Redwood Systemic inflammation in unstable angina is the result of myocardial necrosis J Am Coll Cardiol 39 2002 1917 1923
22. R.J. Raymond, G.J. Dehmer, T.C. Theoharides, E.N. Deliargyris Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction Am Heart J 141 2001 435 438